DEFENCE THERAPEUTICS INC (DTCFF:OTCMKTS)

$0.283 0.0068 (2.462%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 70

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed DEFENCE THERAPEUTICS INC (DTCFF:OTCMKTS) News Sources

Defence Therapeutics Appoints Seasoned Biopharmaceutical Executive Dr John Beaver to Its Board of Directors

03-06-2026

yahoo.com

Defence Therapeutics to Participate in Bio International Convention 2026 Next Week for Strategic Partnership Discussions

17-06-2026

yahoo.com

Defence Therapeutics Opens New Office in Hamilton to Expand Its Accum Radiopharmaceutical Platform

08-07-2026

yahoo.com

Defence Therapeutics Strengthens Radiopharmaceutical Leadership with Appointment of Dr. Ryan Simms as Chief Operating Officer and Head of Radiopharmaceutical Programs

17-08-2026

yahoo.com

Defence Therapeutics Expands Radiopharmaceutical Development Strategy with Alpha and Beta-Emitter Programs

31-08-2026

yahoo.com

Defence Therapeutics Provides Updates on Sharing Agreement

04-09-2026

yahoo.com

Defence Therapeutics CEO Highlights Recent Progress and Outlines Strategic Priorities in Letter to Shareholders

08-09-2026

yahoo.com

Defence Therapeutics Provides Corporate Update as Company Executes on Strategic Priorities

28-09-2026

yahoo.com

Defence Therapeutics Appoints Finance Executive Sherry Aulin to Its Board of Directors

29-09-2026

yahoo.com

Defence Therapeutics to Take the Stage at World ADC San Diego to Discuss the Next Frontier in Antibody-Drug Conjugates

01-10-2026

yahoo.com

DEFENCE THERAPEUTICS INC (DTCFF:OTCMKTS) Sentiment Trend

0 25 50 75 100 74 67 78 66 81 73 66 58 65 77 03-06-2026 17-06-2026 08-07-2026 17-08-2026 31-08-2026 04-09-2026 08-09-2026 28-09-2026 29-09-2026 01-10-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

DEFENCE THERAPEUTICS INC (DTCFF:OTCMKTS) FAQs

toggle

What is the current price of DEFENCE THERAPEUTICS INC (DTCFF:OTCMKTS)?

The current price of DEFENCE THERAPEUTICS INC (DTCFF:OTCMKTS) is $0.283.


toggle

DEFENCE THERAPEUTICS INC (DTCFF:OTCMKTS) absolute price change since previous trading day?

The absolute price change of DEFENCE THERAPEUTICS INC (DTCFF:OTCMKTS) since the previous trading day is $0.0068.


toggle

DEFENCE THERAPEUTICS INC (DTCFF:OTCMKTS) percentage price change since previous trading day?

The percentage price change of DEFENCE THERAPEUTICS INC (DTCFF:OTCMKTS) since the previous trading day is 2.462%.


toggle

What is the most recent average sentiment score for DEFENCE THERAPEUTICS INC (DTCFF:OTCMKTS)?

The most recent average sentiment score for DEFENCE THERAPEUTICS INC (DTCFF:OTCMKTS) is 70 out of 100.


toggle

What is the most recent average sentiment for DEFENCE THERAPEUTICS INC (DTCFF:OTCMKTS)?

The most recent sentiment for DEFENCE THERAPEUTICS INC (DTCFF:OTCMKTS) is .


SEC-8K** Filing Available For DEFENCE THERAPEUTICS INC (DTCFF:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.